Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 726–750 of 7,816 matching trials · page 30 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus) NCT04777409 Semaglutide; Placebo (semaglutide) Runs in: Argentina; Australia; Austria; Belgium; Brazil; Bulgaria;... · 498 sites |
PHASE3 GLP-1 |
COMPLETED | 1,840 | Novo Nordisk A/S INDUSTRY |
2026-06-26 |
|
The Synapse Project NCT04871074 UCB-J; MRI Scan; PET Scan Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 100 | University of Wisconsin, Madison OTHER |
2026-06-26 |
|
Automated, Assistive, Non-Contact Sleep Quality Monitor for Individuals With Alzheimer's Disease NCT06045988 Non-Contact Sleep Quality Monitor System Runs in: United States · 1 site |
NA other |
NOT_YET_RECRUITING | 100 | Indiana University OTHER |
2026-06-26 |
|
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease NCT07094516 VHB937; VHB937; Placebo Runs in: Australia; Canada; China; Czechia; France; Germany; Italy... · 74 sites |
PHASE2 other |
RECRUITING | 407 | Novartis Pharmaceuticals INDUSTRY |
2026-06-26 |
|
Remote Technologies in Early Stages of Alzheimer's Disease NCT07521865 App-based cognitive training Runs in: Switzerland · 1 site |
NA other |
COMPLETED | 52 | University of Bern OTHER |
2026-06-26 |
|
Effects of Ginkgo Biloba on Blood Biomarkers in Mild Cognitive Impairment NCT07579689 Ginkgo Biloba Extract 240 mg; Placebo |
PHASE4 other |
NOT_YET_RECRUITING | 120 | Hanyang University OTHER |
2026-06-26 |
|
Far-Infrared Therapy for the Effect of Alzheimer Disease Dementia NCT07672171 Yin Fu Rui De Far-Infrared Radiator; Sham Far-Infrared Radiator Runs in: Taiwan · 1 site |
NA other |
RECRUITING | 40 | Juin-Hong Cherng OTHER |
2026-06-26 |
|
Trial of Parkinson's And Zoledronic Acid NCT03924414 Zoledronic Acid 5Mg/Bag 100Ml Inj; Placebo Runs in: United States · 77 sites |
PHASE4 other |
COMPLETED | 2,721 | California Pacific Medical Center Research Institute OTHER |
2026-06-25 |
|
Persons With Dementia and Their Extended Family Caregivers NCT04863859 Runs in: United States · 1 site |
NA other |
COMPLETED | 275 | Karen Roberto OTHER |
2026-06-25 |
|
Primary Care Detection of Cognitive Impairment Leveraging Health & Consumer Technologies in Underserved Communities: The MyCog Trial NCT05607732 MyCog Runs in: United States · 1 site |
NA other |
ACTIVE_NOT_RECRUITING | 57,738 | Northwestern University OTHER |
2026-06-25 |
|
Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease NCT05924425 Daridorexant 50 mg; Placebo; Polysomnography; Neuropsychological as... Runs in: France · 1 site |
PHASE4 other |
RECRUITING | 62 | University Hospital, Montpellier OTHER |
2026-06-25 |
|
Impact of Intensive Computerized Cognitive Training NCT06130735 Cognitive Computerized Training Runs in: United States · 1 site |
NA other |
ACTIVE_NOT_RECRUITING | 30 | Brigham and Women's Hospital OTHER |
2026-06-25 |
|
Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects NCT06304883 Experimental: ALZ-801 Runs in: Canada; United Kingdom; United States · 41 sites |
PHASE3 anti-amyloid-aggregation |
TERMINATED | 163 | Alzheon Inc. INDUSTRY |
2026-06-25 |
|
An Open-Label Study to Assess the Long-term Safety of AXS-05 in Subjects With Dementia of the Alzheimer's Type, ADVANCE-2 and ACCORD-2 Extension Study NCT06736509 AXS-05 (dextromethorphan-bupropion) Runs in: Puerto Rico; United States · 22 sites |
PHASE3 other |
TERMINATED | 139 | Axsome Therapeutics, Inc. INDUSTRY |
2026-06-25 |
|
Deep Learning on Amyloid Positons Emission Tomography NCT07309107 Runs in: France · 3 sites |
NA other |
RECRUITING | 40 | Central Hospital, Nancy, France OTHER |
2026-06-25 |
|
The Use of Rhythmic Light Therapy in Mild Cognitive Impairment NCT07318038 Flickering Light Runs in: United States · 1 site |
NA other |
COMPLETED | 20 | Icahn School of Medicine at Mount Sinai OTHER |
2026-06-25 |
|
NON-INVASIVE BRAIN STIMULATION FOR MEMORY LOSS IN EARLY ALZHEIMER'S DISEASE NCT07667478 repetitive transcranial magnetic stimulation (rTMS); sham repetitiv... Runs in: United States · 1 site |
NA other |
RECRUITING | 40 | Chi-Ying (Roy) Lin OTHER |
2026-06-25 |
|
Deep Cervical Lymphovenous Anastomosis for Severe Alzheimer's Disease NCT07669272 Deep Cervical Lymphovenous Anastomosis; Routine Treatment Runs in: China · 1 site |
NA other |
NOT_YET_RECRUITING | 59 | Southwest Hospital, China OTHER |
2026-06-25 |
|
Research of Biomarkers in Parkinson Disease NCT00465790 Runs in: Croatia; France; Germany; Slovenia · 5 sites |
NA other |
COMPLETED | 219 | Institut National de la Santé Et de la Recherche Médicale, France OTHER_GOV |
2026-06-24 |
|
Exploration of the Enteric Nervous System in Alzheimer Disease NCT03472183 biopsies of colon |
NA other |
WITHDRAWN | 0 | Nantes University Hospital OTHER |
2026-06-24 |
|
Time Restricted Eating for Metabolic and Psychological Optimization NCT05997316 Time restricted eating Runs in: United States · 1 site |
NA other |
COMPLETED | 33 | University of North Carolina, Chapel Hill OTHER |
2026-06-24 |
|
Learning Amyloid and Tau Results NCT07222930 Disclose amyloid, tau results; Follow-up Assessments Runs in: United States · 1 site |
NA other |
ENROLLING_BY_INVITATION | 240 | University of Wisconsin, Madison OTHER |
2026-06-24 |
|
Harmonization of Teleneuropsychological Assessment in Dementia NCT07664865 Runs in: Italy · 1 site |
NA other |
COMPLETED | 250 | IRCCS National Neurological Institute "C. Mondino" Foundation OTHER |
2026-06-24 |
|
Blood-based Biomarkers for Alzheimer's Disease at the Primary Care Level. NCT07666113 ptau217 Runs in: Belgium · 1 site |
NA other |
RECRUITING | 240 | Universitaire Ziekenhuizen KU Leuven OTHER |
2026-06-24 |
|
Imaging of Brain Amyloid Plaques in the Aging Population NCT00950430 Pittsburgh Compound B (C-11 PiB); F-18 FDG; Tau (18-F-AV-1451) Runs in: United States · 1 site |
PHASE4 other |
ENROLLING_BY_INVITATION | 8,000 | Mayo Clinic OTHER |
2026-06-23 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial